Multicentre surveillance is essential in order to monitor the prevalence of certain resistance phenotypes and to identify rapidly the emergence of new ones. However, many surveillance studies are based either on a relatively small number of isolates from a single country, or on a large number of isolates from many different countries and so are not equally meaningful. Extensive national multicentre surveillance would provide a more reliable strategy for assessing the extent of antimicrobial resistance in individual countries. This article describes Spanish experience with the surveillance network SAUCE, and summarizes the main results on antimicrobial resistance in the three key bacterial pathogens involved in community-acquired respiratory tract infections in Spain: Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes.
Introduction
Valid assessments of antimicrobial resistance patterns within specified areas are difficult to achieve. Until recently only local, small-scale studies of resistance were used to assess the extent of resistance for a given country. However, the generalization of those results to the whole country was of questionable validity.
To address this issue, there are a number of important considerations to be taken into account. First, it is necessary to determine a geographical setting and the most suitable spatial granularity from which conclusions can be drawn and applied. Sentinel centres working as a network, ideally with a single central laboratory to standardize tests, would be the most appropriate framework. Spain, with one of the highest rates of resistance to many drugs in many different species, was the subject of this surveillance project.
It is essential to define the infections and potential pathogens to be studied. This report focuses on communityacquired respiratory tract infections, namely acute pharyngitis, acute otitis media, acute exacerbations of chronic bronchitis and pneumonias, and their potential pathogens Streptococcus pneumoniae, Streptococcus pyogenes and other β-haemolytic streptococci, Haemophilus influenzae and Moraxella catarrhalis.
Materials and methods
In 1996 a national 'joint-venture' was set up involving public hospitals and universities, the National Institute of Health Carlos III and private initiative with the sponsorship of SmithKline Beecham (currently GlaxoSmithKline) and the participation of the Valencian Institute for Microbiology. This project came to be called SAUCE, an acronym standing for 'Susceptibility to the Antimicrobials Used in the Community in España', which is also the Spanish word for willow tree. The project was conducted under the auspices of the Spanish Surveillance Group for Respiratory Pathogens, which consisted of representatives of each centre and co-workers, who share the authorship of any publication generated by the collective group's effort.
Over a continuous 365 day period non-duplicate isolates were collected from patients with the conditions listed above. Only those isolates that would have been considered diagnostically relevant would be further processed and reported, in order to estimate the prevalence of resistance to antibiotics In Spain all microbiology laboratory investigations are undertaken in larger secondary or tertiary hospitals. Only local differences in the frequency with which microbiological investigation is considered worthwhile for an individual patient and/or differences in laboratory procedure could contribute to potential bias.
Other objectives of the SAUCE project are the rapid identification and tracking of rare phenotypes, and the acquisition of a defined collection of isolates for more detailed studies (molecular epidemiology, in vitro or animal models) that would be readily available on request to any member of the group. Consequently, huge databases were created that allow for comparisons between different provinces, age groups, type of sample and time-point estimates of resistance rates in different bacteria for different antibiotics. These databases can also be used to link with demographic variables or antibiotic consumption.
The value of the SAUCE project has been endorsed by a number of publications in important peer-reviewed journals. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] At present, this initiative is considered to provide the most reliable, up-to-date and comprehensive information on antimicrobial resistance in respiratory pathogens in Spain. Accurate data on resistance rates in respiratory pathogens are essential to an evidence-based approach to empirical therapy of respiratory infections.
Results and discussion
Since detailed results have already been published, the present article will focus on the most important data for S. pneumoniae, H. influenzae and S. pyogenes, giving a general comparative overview of the findings from the first two studies, and paediatric and adult isolates of S. pneumoniae. Results for S. pneumoniae are summarized in Tables 1  and 2, whereas Tables 3 and 4 show the results for S. pyogenes and H. influenzae, respectively.
It is plain that for S. pneumoniae (Table 1 ) a decrease in the frequency of resistance to all oral β-lactams took place (except for co-amoxiclav, which had a very low resistance level in 1996-1997), averaging 21.7% for penicillin, 5.1% for co-amoxiclav, 41.6% for cefaclor and 31.4% for cefuroxime axetil. This is also consistent with a decrease in the MIC 90 of penicillin. As regards macrolides, the prevalence of resistance did not change, with a small trend towards increase (prevalence of resistance 35%), and intrinsic activity (MIC) that was confirmed to be ≥64 mg/L of the three drugs tested. Resistance to ciprofloxacin (as defined by an arbitrary break- 10 (in contrast to American reports), and is therefore linked with resistance to 16-membered macrolides and lincosamides.
In the SAUCE 2 surveillance, 5% of pneumococcal isolates showed an MIC of amoxicillin of ≥8 mg/L, and therefore were categorized as highly resistant. Interestingly, serotype 14 accounted for 46% of these isolates, in contrast to 9% in the overall study. More than two-thirds came from northern centres compared with only 6% from southern Spain. Penicillin MICs for these strains were two or three two-fold dilutions lower than those of amoxicillin, as reported elsewhere 12 . Multiresistance was the rule, since non-susceptibility of these strains was total for penicillin, co-amoxiclav, cefaclor, cefuroxime, and even cefotaxime; up to 65% were also resistant to macrolides and 12% had a ciprofloxacin MIC of ≥4 mg/L. A study is currently underway to address the likely clonal relatedness of these isolates, as seems to be the case (E. Pérez-Trallero, San Sebastián, personal communication).
Co-resistance could also be assessed. Results from SAUCE 2 indicate that for strains showing intermediate resistance to penicillin, both amoxicillin and cefuroxime axetil are suitable oral therapy alternatives (1% and 36%, respectively, were resistant). Only amoxicillin may be suitable for highly penicillin-resistant strains (of which 23% were amoxicillin resistant); of these, 9% were resistant to ciprofloxacin and so newer fluoroquinolones could be a valid option. Particularly concerning is the increase in resistance to erythromycin (and therefore to clarithromycin and azithromycin) among penicillin-susceptible isolates, with a current 11% resistance (and ∼60% for both intermediate and highlevel penicillin resistance). No less worrying is the association of resistance to ciprofloxacin and erythromycin on one hand, and penicillin non-susceptibility on the other. Resist- ance to ciprofloxacin might therefore increase even in the absence of selective pressure by quinolones, driven by coselector antibiotics. Analysis of the pulsed-field gel electrophoretic profiles of pneumococcal isolates with reduced susceptibility to ciprofloxacin and of co-occurring susceptible isolates indicates a considerable genetic diversity among the former isolates and points to a close relationship between the two groups. This suggests that strains with reduced susceptibility to ciprofloxacin emerge through independent mutational events. However, up to 30% of the isolates belonged to two internationally spread multidrug-resistant epidemic clones: Spain 23F -1 and Spain 9V -3, implying that dissemination of ciprofloxacin resistance through these isolates may be likely to occur in Spain. 8 Another interesting ecological association that has been consistently found in the two surveys performed so far is the correlation between the prevalence of erythromycin resistance by site in S. pneumoniae and S. pyogenes. 5, 10 Since these two species are epidemiologically unrelated, and their mechanisms of resistance are distinct, there must be some force driving this co-selection of resistance.
Paediatric isolates represented 11% and 17% of the SAUCE 1 and SAUCE 2 pneumococcal strains. As has been widely reported, rates of resistance in this subpopulation (Table 2 ) also tended to be higher than in the whole population. Particularly striking was the fact that in the SAUCE 1 surveillance, more than half of these isolates were highly resistant to penicillin (50.4%), cefaclor (68%) and cefuroxime axetil (54%), ∼40% were resistant to macrolides, but only 5.6% were highly resistant to co-amoxiclav (MIC 90 4 mg/L). The apparent decrease in resistance in the SAUCE 2 surveillance was also mirrored in isolates from children: prevalence of high-level resistance of 28% for penicillin, 50% for cefaclor and macrolides, 40% for cefuroxime axetil and only 7% for co-amoxiclav.
As far as S. pyogenes is concerned (Table 3) , the main finding is an apparent decrease in the raw estimation of resistance to erythromycin from 25% in SAUCE 1 to 20% in SAUCE 2. This reduction is probably an underestimate due to a greater contribution of isolates from northern centres with a low resistance rate in the latter survey. By assigning the same relative weight to every province, regardless of the number of isolates provided, a prevalence of erythromycin resistance of 29% would be obtained.
The M phenotype (efflux pump) accounts for 90% of this resistance, in contrast to S. pneumoniae. Erythromycin resistance is mainly due to a few M types, predominantly M4. 13 This association between resistance to erythromycin and ciprofloxacin in S. pneumoniae also occurs with S. pyogenes (6.1% compared with 2.7% ciprofloxacin resistance for erythromycin-resistant and -susceptible isolates, respectively) in the last survey, paving the way for further increases in resistance to ciprofloxacin driven by macrolides.
Regarding H. influenzae (Table 4) , β-lactamase was found in 25% of isolates (no apparent change over time), which is lower than the 30-35% reported by others. 14, 15 The β-lactamase production status influenced only the susceptibility to ampicillin and cefaclor, but not that to cefuroxime. Of H. influenzae isolates from SAUCE 2, 9% were of the β-lactamase-negative ampicillin-resistant (BLNAR) phenotype, since they were neither fully susceptible to ampicillin, nor producers of β-lactamase. Differences in the intrinsic potency of macrolides were also seen, with clarithromycin being less active than azithromycin. The data presented in the tables are average estimates of the results obtained by each hospital, and may lead to the misleading image that prevalence of resistance is homogeneous within the country. But the reality is very different since resistance showed wide variations between provinces. It ranges from 6% to 41% for penicillin and from 22% to 61% for erythromycin in S. pneumoniae; from 11% to 49% for erythromycin in S. pyogenes and from 16% to 30% for β-lactamase production in H. influenzae (not statistically significant in this latter case) in the SAUCE 2 survey.
In conclusion, it can be affirmed that the Spanish experience with the SAUCE project has optimized resources and has become an essential reference, offering the most reliable and comprehensive data on resistance in key respiratory bacteria in Spain. It is expected that the ongoing third SAUCE survey will update even more accurately the information generated so far, and at the same time more profound studies on molecular mechanisms of resistance and epidemiology of the isolates obtained will clarify the complexity of antimicrobial resistance. Similar autonomous networks in other countries are likely to be more valuable, efficient, feasible and less costly than huge multinational surveillance studies.
